<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
AMENDMENT NO. 2
BOSTON CELTICS LIMITED PARTNERSHIP
- --------------------------------------------------------------------------------
(Name of Issuer)
Limited Partnership Units
- --------------------------------------------------------------------------------
(Title of Class of Securities)
100577105
- --------------------------------------------------------------------------------
(CUSIP number)
Paul E. Gaston
33 East 63rd Street
New York, NY 10021
(212) 644-3800
- --------------------------------------------------------------------------------
(Name, address and telephone number of person
authorized to receive notices and communications)
March 13, 2000
- --------------------------------------------------------------------------------
(Date of event which requires filing of this statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check
the following box [_].
Note. Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7(b) for
other parties to whom copies are to be sent.
<PAGE>
- ----------------------- ---------------------
CUSIP NO. 100577105 13D PAGE 2 OF 7 PAGES
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Castle Creek Partners, L.P.
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [X]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
SOURCE OF FUNDS*
4
WC
- ------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
5 PURSUANT TO ITEMS 2(d) or 2(e) [_]
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
DELAWARE
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF
617,900
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
OWNED BY 0
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING
617,900
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
0
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
617,900
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12 [_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
22.9%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
14
PN
- ------------------------------------------------------------------------------
(Page 2 of 7 pages)
<PAGE>
- ----------------------- ---------------------
CUSIP NO. 100577105 13D PAGE 3 OF 7 PAGES
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Castle Creek Partners GP, Inc.
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [X]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
SOURCE OF FUNDS*
4
- ------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
5 PURSUANT TO ITEMS 2(d) or 2(e) [_]
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
DELAWARE
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF
617,900
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
OWNED BY 0
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING
617,900
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
0
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
617,900
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12 [_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
22.9%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
14
CO
- ------------------------------------------------------------------------------
(Page 3 of 7 pages)
<PAGE>
- ----------------------- ---------------------
CUSIP NO. 100577105 13D PAGE 4 OF 7 PAGES
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Paul E. Gaston
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [X]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
SOURCE OF FUNDS*
4
- ------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
5 PURSUANT TO ITEMS 2(d) or 2(e) [_]
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
USA
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF
618,000
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
OWNED BY 0
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING
618,000
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
0
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
618,000
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12 [_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
22.9%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
14
IN
- ------------------------------------------------------------------------------
(Page 4 of 7 pages)
<PAGE>
This Amendment No. 2 to Schedule 13D is being filed in connection with open
market purchases of limited partnership units (the "Units") of Boston Celtics
Limited Partnership ("BCLP") by Castle Creek Partners, L.P. ("Castle Creek").
Capitalized terms not defined in this amendment have the meanings given to them
in Schedule 13D.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
Item 3 of Schedule 13D is hereby amended by adding the information set
forth below to the information previously disclosed therein.
Castle Creek purchased the Units described in Item 5 of this Amendment No.
2 with cash and proceeds from short-term investments.
ITEM 4. PURPOSE OF TRANSACTION
Item 4 of Schedule 13D is hereby amended by adding the information set
forth below to the information previously disclosed therein.
The purpose of the acquisitions of Units described in Item 5 of this
Amendment No. 2 by Castle Creek was for Castle Creek to increase its equity
interest in BCLP for investment purposes. Prior to the acquisitions described
in Item 5 of this Amendment No. 2, Castle Creek owned 21.6% of the outstanding
Units. The additional acquisitions described in this Amendment No. 2 increased
Castle Creek's ownership interest in BCLP to 22.9% of the outstanding Units.
The purpose of the additional acquisitions described herein was not for Castle
Creek or Paul E. Gaston to acquire or influence control of BCLP's business,
since Castle Creek previously owned 21.6% of the outstanding Units and since
BCLP GP, Inc., an affiliate of Castle Creek and Paul E. Gaston, was already
BCLP's general partner. By virtue of ownership of over 20% of the outstanding
Units, Castle Creek and Paul E. Gaston can prevent certain actions that,
pursuant to BCLP's Agreement of Limited Partnership, require a vote of at least
80% of the outstanding Units.
Except as set forth above and elsewhere in this Amendment No. 2, Castle
Creek, Castle Creek GP and Paul E. Gaston have no present plans or intentions
that relate to or would result in any of the transactions described in clauses
(a) through (j) of Item 4 of Schedule 13D. Depending on market prices and other
factors, Castle Creek may, from time to time, purchase additional Units. The
intentions of Castle Creek, Castle Creek GP and Paul E. Gaston and entities with
respect to BCLP and the Units are subject to change, and each retains its right
to modify its plans with respect to the transactions described in this Item 4,
to acquire or dispose of securities of BCLP and to formulate plans and proposals
that could result in the occurrence of any such events.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
Item 5 of Schedule 13D is hereby amended and restated as follows.
(a) Castle Creek directly and beneficially owns 617,900 Units, which
constitute approximately 22.9% of the Units outstanding as of September 30,
1999. As general partner of Castle Creek, Castle Creek GP may be deemed to
beneficially own all Units owned directly by Castle Creek. Paul E. Gaston may
be deemed to beneficially own 618,000 Units, which constitute approximately
22.9% of the Units outstanding as of September 30, 1999, of which 617,900 are
owned directly by Castle Creek, and 100 are owned directly by Walcott.
Don F. Gaston and Paula B. Gaston directly and beneficially own an
aggregate of 200 Units, which constitute less than 1% of the Units outstanding
as of September 30, 1999. Don F. Gaston is deemed to beneficially own 100 Units
owned directly by Brookwood Investments Limited Partnership.
(Page 5 of 7 pages)
<PAGE>
(b) Each person named in response to paragraph (a) of this Item 5 has sole
power to vote or to direct the vote, and sole power to dispose of or to direct
the disposition of, the number of Units beneficially owned by such person.
(c) The following table sets forth information regarding Castle Creek's
acquisition of Units within the past sixty days. All transactions were effected
in the open market on the New York Stock Exchange.
NUMBER OF UNITS WEIGHTED
DATE PURCHASED AVERAGE PRICE
January 18, 2000 1,000 $9.9375
January 20, 2000 100 $9.9375
January 28, 2000 1,000 $9.9375
February 2, 2000 300 $9.9375
February 4, 2000 500 $9.9375
February 7, 2000 200 $9.9375
February 8, 2000 1,500 $9.9375
February 9, 2000 600 $9.9271
February 10, 2000 300 $9.9375
February 11, 2000 600 $9.9375
February 14, 2000 1,000 $9.9063
February 15, 2000 3,500 $9.9375
February 16, 2000 600 $9.9375
February 17, 2000 400 $9.9375
February 22, 2000 3,500 $9.9196
February 23, 2000 1,700 $9.9375
February 24, 2000 1,000 $9.9375
February 25, 2000 1,800 $9.9375
February 29, 2000 1,000 $9.9375
March 1, 2000 100 $9.9375
March 3, 2000 500 $9.9375
March 6, 2000 1,600 $9.9375
March 8, 2000 1,400 $9.8929
March 10, 2000 1,500 $9.9375
March 13, 2000 400 $9.9375
March 14, 2000 1,200 $9.9375
March 15, 2000 5,200 $9.9351
(d) Not applicable.
(e) Not applicable.
(Page 6 of 7 pages)
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: March 16, 2000
CASTLE CREEK PARTNERS, L.P.
By: Castle Creek Partners GP, Inc.
Its: General Partner
/s/ Paul E. Gaston
---------------------------------
By: Paul E. Gaston
Its: President
CASTLE CREEK PARTNERS GP, INC.
/s/ Paul E. Gaston
---------------------------------
By: Paul E. Gaston
Its: President
/s/ Paul E. Gaston
---------------------------------
Paul E. Gaston
(Page 7 of 7 pages)
